The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer.
about
The clinical significance of tumor-infiltrating neutrophils and neutrophil-to-CD8+ lymphocyte ratio in patients with resectable esophageal squamous cell carcinomaRegulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic TargetingExploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinicLocal and systemic XAGE-1b-specific immunity in patients with lung adenocarcinoma.Prognostic factors in resected lung carcinomas.Ratio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma.Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomasPTRF/cavin-1 and MIF proteins are identified as non-small cell lung cancer biomarkers by label-free proteomics.Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.Racotumomab-alum vaccine for the treatment of non-small-cell lung cancer.Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment.Oncogenic Ras stimulates Eiger/TNF exocytosis to promote growth.Comparative network analysis via differential graphlet communities.Tumor microenvironment: a new treatment target for cancerActivation of Toll-like receptors signaling in non-small cell lung cancer cell line induced by tumor-associated macrophagesNovel antigens in non-small cell lung cancer: SP17, AKAP4, and PTTG1 are potential immunotherapeutic targets.Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma.Immunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates with survival in patients with non-small cell lung cancer.A randomized phase II study of radiation induced immune boost in operable non-small cell lung cancer (RadImmune trial).Lung cancer-derived galectin-1 enhances tumorigenic potentiation of tumor-associated dendritic cells by expressing heparin-binding EGF-like growth factor.Glasgow prognostic score predicts prognosis of non-small cell lung cancer: a meta-analysisCellular and molecular immunology of lung cancer: therapeutic implications.Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung CancerPolymorphisms in the intercellular adhesion molecule 1 gene and cancer risk: a meta-analysis.CD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitment.Improved Chemotherapeutic Activity by Morus alba Fruits through Immune Response of Toll-Like Receptor 4.Exosomes in Cancer Microenvironment and Beyond: have we Overlooked these Extracellular Messengers?Resected pancreatic ductal adenocarcinomas with recurrence limited in lung have a significantly better prognosis than those with other recurrence patternsGenetic variations in interleukin-8 and interleukin-10 are associated with pain, depressed mood, and fatigue in lung cancer patientsSurvival in Patients With Severe Lymphopenia Following Treatment With Radiation and Chemotherapy for Newly Diagnosed Solid TumorsInfiltrating T cells promote renal cell carcinoma (RCC) progression via altering the estrogen receptor β-DAB2IP signals.The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma.Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.Aiming to immune elimination of ovarian cancer stem cellsTLR4/ROS/miRNA-21 pathway underlies lipopolysaccharide instructed primary tumor outgrowth in lung cancer patients.Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers.Molecular biology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.Differentiated regulation of immune-response related genes between LUAD and LUSC subtypes of lung cancers.Bronchial airway gene expression in smokers with lung or head and neck cancer.Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer.
P2860
Q21245478-260AB80A-1AC0-4236-B5DC-86E419D0111EQ26742012-BED1543E-802E-4754-A963-0E370474EAA2Q28075992-81E669EE-4265-4D9B-A988-14587F75E7C5Q30661652-F6E7D919-DD75-4371-AC07-3AC708440929Q33697964-3733396B-5F89-4ABC-870A-A686E4BB049DQ34142500-8839C2DA-F5F4-41ED-8EFE-15B5BB4D2C81Q34178633-FCF61649-F3D3-44E8-8EE2-EFA3ECB8AFDFQ34213807-63AECC69-B031-44D4-9A21-376BE93B5FE0Q34367058-13752C06-DE8D-497A-ABBE-5ADF6368530DQ34449304-341F305B-FEB1-45B1-B116-8F8206838D8FQ34502899-A31F26CE-DFD4-4036-A1A1-5163B3C91DD6Q34985765-999F8077-AE6B-4F68-B136-34A58A90F9A4Q35023336-7C93CCE4-88FC-44D8-9480-49FFEDABECD6Q35361431-A26AF6E6-C802-49E9-B9A2-FFB473F96156Q35538723-8DD04A6A-2DCE-45EE-AE63-ED33B4AC3696Q35550108-4EBE689D-90CA-40C5-B0AB-CDDD244716B3Q35790271-E7C10F72-4A9E-45B1-B4B2-9B98468F8853Q35799185-96416FC9-FA87-4B6A-81B4-4FCEB28A0463Q35873571-8CBB92C4-515F-48BE-8741-E67B92CC1B83Q35879907-F7EFF8BB-A077-4958-8422-B5DEBC879BD3Q35996748-9EEBF1E2-7BF0-466D-81D4-304D3FC82AE1Q36130505-0C9EA683-EE13-4E01-8672-5B8FA653B50EQ36151154-DC44DC9D-7590-49D5-A328-A48645738382Q36182588-A2679F47-FFA6-48D4-B926-1EC28FBB06EFQ36242193-A1495B74-1712-4DEA-B09B-D4822494C4BCQ36247376-B45E32A0-C2BE-46B1-A8B6-AE34C31EAE07Q36284966-7464F4EC-FBC7-4F9B-9822-8B78B9AE44A7Q36546827-D386E6D0-0A94-4021-B7A7-DE1C44319BA6Q36625873-2230BAD0-86DC-4528-A130-ECB8045D87B5Q36652138-2D8862AF-83B7-4FD3-9E49-B2CA8A7B7EB7Q36688972-216D41F5-1948-4CE5-BA57-DE01F020F3A7Q36772177-DEEFE7E6-8E71-4957-9EE1-61A119A98318Q36916445-2A9B3300-9CE9-4C62-8835-E066A641F284Q37266548-F523D938-F147-4B55-85EB-C66766BA2D31Q37520487-2790F585-59BF-4C02-81FB-ABCC21134D3DQ37619675-6ACA28F2-FF23-46D7-91E0-860FD7D829B9Q37653893-66A8A7C0-6AA5-4AE2-A6D5-7573E8DBC800Q37702094-30C8D510-597B-4990-81A1-1D2661DB1D6DQ37703387-9B9656F2-8E84-47BB-B621-18A76E7FE812Q37711669-AC2704D2-3680-4F59-BBE1-55E00502020D
P2860
The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of tumor-infiltrating ...... on non-small cell lung cancer.
@en
The role of tumor-infiltrating ...... on non-small cell lung cancer.
@nl
type
label
The role of tumor-infiltrating ...... on non-small cell lung cancer.
@en
The role of tumor-infiltrating ...... on non-small cell lung cancer.
@nl
prefLabel
The role of tumor-infiltrating ...... on non-small cell lung cancer.
@en
The role of tumor-infiltrating ...... on non-small cell lung cancer.
@nl
P2093
P50
P1476
The role of tumor-infiltrating ...... on non-small cell lung cancer.
@en
P2093
Helge Stenvold
Khalid Al-Shibli
Lill-Tove Busund
Roy M Bremnes
Sigve Andersen
Tom Donnem
P304
P356
10.1097/JTO.0B013E3182037B76
P577
2011-04-01T00:00:00Z